Dermatologic reaction(such as Steven Johnson syndrome ) have been report in post marketing surveillance . Discontinuoue if symptom of hypersensitivity reaction occur . Use with caution if patient has experience angioedema with other dpp-Iv inhibitor use. Case of acute